Rozenbaum W
Service des Maladies Infectieuses, Hôpital Rothschild, Pris.
Allerg Immunol (Paris). 1994 Apr;26(4):153-5.
Availability to practitioners of a treatment for infections by atypical mycobacteria by Ansatipine should produce a reduction or delay in the frequency of opportunistic infections in AIDS, which are a heavy burden on the future of the patients and seriously after their quality of life. Today, the practice of prescribing Ansatipine increase the prophylactic strategy for opportunistic infections in AIDS, or the "Umbrella strategy". This can only improve the possible therapies for practitioners who are faced with the complexity of the disease and bring real benefit to the patients. Distribution of Ansatipine to town pharmacies is a new step in this direction.
安沙替平可为从业者提供一种治疗非典型分枝杆菌感染的方法，这有望减少或延缓艾滋病患者机会性感染的发生频率，机会性感染给患者的未来带来沉重负担，并严重影响他们的生活质量。如今，开具安沙替平的做法增加了艾滋病机会性感染的预防策略，即“伞状策略”。这只会改善面临该疾病复杂性的从业者可能采用的治疗方法，并给患者带来切实益处。将安沙替平投放至城镇药店是朝着这个方向迈出的新一步。
